Trial intelligence / Profile preview

Intraportal Chemotherapy + mFOLFOX6 in Colon Cancer

NCT02402972Phase 3Unknown

Start
Feb 2015
Primary completion
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of floxuridine in colon cancer. Status: unknown.

02

Drugs

floxuridine
03

Conditions

colon cancer

Beyond the preview

Go deeper on NCT02402972.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02402972.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call